close

Fundraisings and IPOs

1 2 3 4 67
Number of results: 1334
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-11-10 Transgene (France) € 14.4 million capital increase qualified U.S. and European institutional investors including Institut Mérieux (France) and Dassault Belgique Aviation Cancer - Oncology - Infectious diseases Capital increase
2017-11-06 Nouscom (Switzerland) €42 Million series B financing round Abingworth (UK) 5AM Ventures (USA - CA) LSP (The Netherlands) Versant Ventures. (USA - CA) Cancer - Oncology Series B financing round
2017-10-16 Antabio (France) € 7.3 million series A financing round iXO Private Equity (France) IRDI SORIDEC Gestion (France) Galia Gestion (France) and company’s historical investors including former President of OM Pharma Christophe Ricard. Rare diseases - Infectious diseases Series A financing round
2017-09-22 DaVolterra (France) € 20 million loan European Investment Bank (EIB) Infectious diseases Loan
2017-09-18 Evotec (Germany) up to € 75 million loan European Investment Bank (EIB) Technology - Services Loan
2017-09-18 Soligenix (USA - NJ) $1.5 million grant National Cancer Institute (NCI) (USA) Cancer - Oncology Grant
2017-08-28 Apeiron Biologics (Austria) € 25 million grant European Investment Bank (EIB) Cancer - Oncology Grant
2017-08-15 Omeros (USA - Wn) private placement Private placement
2017-08-09 Spark Therapeutics (USA - PA) $380.4 million private placement Private placement
2017-08-08 Radius Health (USA - MA) $300 million private placement Bone diseases - Cancer - Oncology - Endocronological diseases Private placement
2017-08-07 Cuorips (Japan) investment Daiichi Sankyo (Japan) Fundraising
2017-08-04 Lonza (Switzerland) € 700 million and $ 200 million private placement Technology - Services Company acquisition
2017-07-28 Iteos Therapeutics (Belgium) € 7.5 million grant Walloon Region (Belgium) Cancer - Oncology Grant
2017-07-26 Quantum Genomics (France) € 8.2 Million capital increase Cardiovascular diseases Capital increase
2017-07-25 Antabio (France) up to $8.9 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Debiopharm (Switzerland) up to $ 4 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Achaogen (USA - CA) up to $ 11.5 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Bugworks Research Inidia (India) up to $ 6.2 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Eligochem (UK) up to $ 4.8 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant
2017-07-25 Iterum Therapeutics (Ireland) up to $ 1.5 million grant Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB - X) (USA - MA) Infectious diseases Grant